Both in Biotechnology
Pelthos Therapeutics vs Elutia
Over the past year PTHS returned −70.4% and ELUT returned −16.8%; their daily moves had a correlation of 0.05.
PTHS −70.4% ELUT −16.8%Growth of $1, one year, split-adjusted
| Metric | PTHS | ELUT |
|---|---|---|
| Price | $10.14 | $0.7781 |
| Market cap | $39.9M | $34.5M |
| Today | −5.94% | −4.32% |
| 1 month | −52.8% | +0.2% |
| 6 months | −59.4% | −23.7% |
| Year to date | −67.3% | +12.3% |
| 1 year | — | −16.8% |
| Revenue growth (YoY) | — | −11.6% |
| Gross margin | 76.9% | 59.6% |
| Net margin | −150.1% | −315.0% |
| P/E (TTM) | — | 0.7× |
| Price / sales | 0.9× | 2.8× |
| Net cash | -$45.7M | $19.9M |
| Dividend yield | — | — |
| Volatility (60d) | 140.7% | 61.4% |
| Short % of float | 8.6% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).